{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T06:10:07Z","timestamp":1759471807344,"version":"build-2065373602"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Diabetic Ketoacidosis (DKA) is a life-threatening complication of uncontrolled diabetes. The COVID-19 pandemic may have increased DKA incidences and worsened outcomes both through the potential diabetogenic effects of SARS-CoV-2 infection (direct effect) and through pandemic-related disruptions in healthcare (indirect effects,) including delays in seeking or receiving care, reduced access to routine outpatient services, and strains on hospital capacity. The objective of this study is to examine changes in the frequency and outcomes of hospitalizations with DKA in Texas hospitals following the COVID-19 pandemic and to quantify the contributions of pandemic-related healthcare disruptions and SARS-CoV-2 infection. Comparisons to patients with Acute Myocardial Infarction (AMI) and Acute Kidney Injury (AKI) were made to assess the disproportionate impacts of healthcare system disruptions on DKA patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective observational study uses regression analyses to evaluate the relative contributions of healthcare disruptions and viral infection on DKA frequency, in-hospital mortality, and length of stay. Event study and difference-in-differences models are employed to analyze whether DKA cases were disproportionately affected compared to patients with AMI or AKI. Quarterly inpatient discharge records from 2018 to 2021 are obtained from the Texas Department of State Health Services. Over 8 million discharge records are examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>DKA hospitalizations increased by 8% post-pandemic, with half of the increase attributable to pandemic-induced healthcare disruptions (indirect effects.) The average mortality of patients with DKA increased by 44% compared to the pre-pandemic average. Non-COVID channels contributed to a 30% increase in mortality. Compared to AMI and AKI patients, DKA patients were disproportionately affected by pandemic-induced disruptions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The COVID-19 pandemic significantly impacted DKA outcomes through the direct effects of SARS-CoV-2 infection and through various healthcare system disruptions\u2014such as reduced access to routine diabetes care, delays in seeking treatment, and hospital resource constraints. Policies supporting uninterrupted diabetes management, such as telemedicine and medication access programs may reduce adverse outcomes in future health crises.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1597297","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T05:29:10Z","timestamp":1759469350000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pandemic-driven healthcare disruptions and their disproportionate impact on patients with diabetes: evidence from Texas"],"prefix":"10.3389","volume":"13","author":[{"given":"Meryem","family":"Saygili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gultekin","family":"Gollu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehra","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"ref1","year":"2024"},{"key":"ref2","year":""},{"key":"ref3","doi-asserted-by":"publisher","first-page":"108291","DOI":"10.1016\/j.diabres.2020.108291","article-title":"High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care","volume":"166","author":"Goldman","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"102389","DOI":"10.1016\/j.dsx.2022.102389","article-title":"The impact of COVID-19 on diabetic ketoacidosis patients","volume":"16","author":"Khan","year":"2022","journal-title":"Diabet Metabol Synd"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.dsx.2020.07.050","article-title":"Diabetic ketoacidosis precipitated by COVID-19: a report of two cases and review of literature","volume":"14","author":"Reddy","year":"2020","journal-title":"Diabet Metabol Synd"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e3319","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","volume":"36","author":"Guo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e211091","DOI":"10.1001\/jamanetworkopen.2021.1091","article-title":"Characteristics of and mortality associated with diabetic ketoacidosis among US patients hospitalized with or without COVID-19","volume":"4","author":"Pasquel","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/diabetology3030036","article-title":"Diabetic ketoacidosis was associated with high morbidity and mortality in hospitalized patients with COVID-19 in the NYC public health system","volume":"3","author":"Parthasarathy","year":"2022","journal-title":"Diabetology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.2337\/dc20-1321","article-title":"Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children?","volume":"43","author":"Rabbone","year":"2020","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/pedi.13205","article-title":"Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic","volume":"22","author":"Ho","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/jamapediatrics.2021.5801","article-title":"Incidence of new-onset type 1 diabetes among US children during the COVID-19 global pandemic","volume":"176","author":"Gottesman","year":"2022","journal-title":"JAMA Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-8587(20)30238-2","article-title":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes","volume":"8","author":"Apicella","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"117955142098412","DOI":"10.1177\/1179551420984125","article-title":"Diabetic ketoacidosis on hospitalization with COVID-19 in a previously nondiabetic patient: a review of pathophysiology","volume":"13","author":"Eskandarani","year":"2020","journal-title":"Clin Med Insights Endocrinol Diabet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/dom.14057","article-title":"COVID-19 infection may cause ketosis and ketoacidosis","volume":"22","author":"Li","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1016\/j.ajem.2020.05.114","article-title":"Newly diagnosed diabetes and diabetic ketoacidosis precipitated by COVID-19 infection","volume":"38","author":"Heaney","year":"2020","journal-title":"Am J Emerg Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"108263","DOI":"10.1016\/j.diabres.2020.108263","article-title":"Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: a retrospective single Centre study","volume":"165","author":"Alkundi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1016\/j.jemermed.2020.07.017","article-title":"First-time diabetic ketoacidosis in type 2 diabetics with COVID-19 infection: a novel case series","volume":"59","author":"Croft","year":"2020","journal-title":"J Emerg Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e0266809","DOI":"10.1371\/journal.pone.0266809","article-title":"The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: a Nationwide cohort from the US using the Cerner real-world data","volume":"17","author":"Qeadan","year":"2022","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2020.13445","article-title":"Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany","volume":"324","author":"Kamrath","year":"2020","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e14417","DOI":"10.1111\/dme.14417","article-title":"Increased pediatric presentations of severe diabetic ketoacidosis in an Australian tertiary Centre during the COVID-19 pandemic","volume":"38","author":"Lawrence","year":"2021","journal-title":"Diabet Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/JDEP.JDEP_45_21","article-title":"The impact of the COVID-19 pandemic on diabetic ketoacidosis admissions to a COVID-19-free hospital","volume":"4","author":"Alnuaimi","year":"2021","journal-title":"J Diabet Endocrine Pract"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/1753-0407.13208","article-title":"Delayed diagnosis of diabetic ketoacidosis and associated mortality during the COVID-19 pandemic","volume":"13","author":"Foster","year":"2021","journal-title":"J Diabetes"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e13591","DOI":"10.1111\/1753-0407.13591","article-title":"Trends in diabetic ketoacidosis- and hyperosmolar hyperglycemic state-related mortality during the COVID-19 pandemic in the United States: a population-based study","volume":"16","author":"He","year":"2024","journal-title":"J Diabetes"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12913-021-06393-5","article-title":"A qualitative study of physician perceptions and experiences of caring for critically ill patients in the context of resource strain during the first wave of the COVID-19 pandemic","volume":"21","author":"Parsons Leigh","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1186\/s12913-024-11362-9","article-title":"Healthcare staff experiences on the impact of COVID-19 on emergency departments: a qualitative study","volume":"24","author":"Butun","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e0272609","DOI":"10.1371\/journal.pone.0272609","article-title":"Patient-reported factors associated with avoidance of in-person care during the COVID-19 pandemic: results from a national survey","volume":"17","author":"Arnetz","year":"2022","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","article-title":"Delay or avoidance of medical care because of COVID-19\u2013related concerns\u2014United States, June 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12913-023-09057-8","article-title":"Disparities in routine healthcare utilization disruptions during COVID-19 pandemic among veterans with type 2 diabetes","volume":"23","author":"Adhikari","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e2132607","DOI":"10.1001\/jamanetworkopen.2021.32607","article-title":"Trends in insulin prescribing for patients with diabetes during the COVID-19 pandemic in the US","volume":"4","author":"Yunusa","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/CCI.20.00068","article-title":"Effects of the COVID-19 pandemic on cancer-related patient encounters","volume":"4","author":"London","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"107748","DOI":"10.1016\/j.jdiacomp.2020.107748","article-title":"The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: a national cohort study","volume":"34","author":"Fisher","year":"2020","journal-title":"J Diabetes Complicat"},{"key":"ref32","year":""},{"key":"ref33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1399-543X.2005.00096.x","article-title":"Increased incidence and severity of diabetic ketoacidosis among uninsured children with newly diagnosed type 1 diabetes mellitus","volume":"6","author":"Maniatis","year":"2005","journal-title":"Pediatr Diabetes"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/SMJ.0b013e3181aa5f5b","article-title":"Health insurance and the development of diabetic complications","volume":"102","author":"Flavin","year":"2009","journal-title":"South Med J"},{"key":"ref35","year":""},{"key":"ref36","doi-asserted-by":"publisher","first-page":"210123","DOI":"10.5888\/pcd18.210123","article-title":"Underlying medical conditions and severe illness among 540, 667 adults hospitalized with COVID-19, march 2020\u2013march 2021","volume":"18","author":"Kompaniyets","year":"2021","journal-title":"Prev Chronic Dis"},{"key":"ref37","first-page":"299","article-title":"The disproportional impact of COVID-19 on African Americans","volume":"22","author":"Vasquez Reyes","year":"2020","journal-title":"Health Hum Rights"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jama.2023.12951","article-title":"Insulin fills by Medicare enrollees and out-of-pocket caps under the inflation reduction act","volume":"330","author":"Myerson","year":"2023","journal-title":"JAMA"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/dci23-0042","article-title":"Lessons from insulin: policy prescriptions for affordable diabetes and obesity medications","volume":"47","author":"Nagel","year":"2024","journal-title":"Diabetes Care"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/a-1352-5023","article-title":"Diabetes care during COVID-19 pandemic in Singapore using a telehealth strategy","volume":"53","author":"Lian","year":"2021","journal-title":"Horm Metab Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e21609","DOI":"10.2196\/21609","article-title":"Virtual consultations and the role of technology during the COVID-19 pandemic for people with type 2 diabetes: the UK perspective","volume":"22","author":"Quinn","year":"2020","journal-title":"J Med Internet Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2337\/dc19-1459","article-title":"Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials","volume":"43","author":"Maiorino","year":"2020","journal-title":"Diabetes Care"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e2336876","DOI":"10.1001\/jamanetworkopen.2023.36876","article-title":"Comprehensive telehealth model to support diabetes self-management","volume":"6","author":"Aleppo","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2213-8587(21)00208-4","article-title":"Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study","volume":"9","author":"Misra","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"110559","DOI":"10.1016\/j.diabres.2023.110559","article-title":"Incidence and presentation of new-onset type 1 diabetes in children and adolescents from Germany during the COVID-19 pandemic 2020 and 2021: current data from the DPV registry","volume":"197","author":"Baechle","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1234256","DOI":"10.3389\/fendo.2023.1234256","article-title":"Uncovering the alarming rise of diabetic ketoacidosis during COVID-19 pandemic: a pioneer African study and review of literature","volume":"14","author":"Gorchane","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S2213-8587(22)00246-7","article-title":"Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries","volume":"10","author":"Birkebaek","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12916-022-02656-y","article-title":"Risk for newly diagnosed diabetes after COVID-19: a systematic review and Meta-analysis","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3390\/biomedicines13061482","article-title":"Post-COVID metabolic fallout: a growing threat of new-onset and exacerbated diabetes","volume":"13","author":"Hemat Jouy","year":"2025","journal-title":"Biomedicine"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1597297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T05:29:11Z","timestamp":1759469351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1597297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":49,"alternative-id":["10.3389\/fpubh.2025.1597297"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1597297","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"article-number":"1597297"}}